SODIUM-DEPENDENT ISOMERIZATION OF DOPAMINE D-2 RECEPTORS CHARACTERIZED USING [I-125] EPIDEPRIDE, A HIGH-AFFINITY SUBSTITUTED BENZAMIDE LIGAND

被引：0
作者：
NEVE, KA
HENNINGSEN, RA
KINZIE, JM
DEPAULIS, T
SCHMIDT, DE
KESSLER, RM
JANOWSKY, A
机构：
[1] OREGON HLTH SCI UNIV, DEPT PSYCHIAT, PORTLAND, OR 97201 USA
[2] OREGON HLTH SCI UNIV, DEPT PHARMACOL, PORTLAND, OR 97201 USA
[3] VANDERBILT UNIV, MED CTR, SCH MED, NASHVILLE, TN 37232 USA
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1990年 / 252卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1108 / 1116
页数：9
相关论文
共 50 条
  • [31] NALOXAZONE IRREVERSIBLY INHIBITS THE HIGH-AFFINITY BINDING OF [I-125]D-ALA2-D-LEU5-ENKEPHALIN
    HAZUM, E
    CHANG, KJ
    CUATRECASAS, P
    PASTERNAK, GW
    LIFE SCIENCES, 1981, 28 (26) : 2973 - 2979
  • [32] NEW FLUORINE-SUBSTITUTED ANALOG OF ETICLOPRIDE WITH HIGH-AFFINITY TOWARD DOPAMINE D2 RECEPTORS
    WATANABE, K
    FUKUMURA, T
    SASAKI, S
    MAEDA, M
    TAKEHARA, S
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1991, 39 (12) : 3211 - 3214
  • [33] D-2 DOPAMINE-RECEPTORS IN AGING MOUSE STRIATUM - DETERMINATION OF HIGH-AFFINITY AND LOW-AFFINITY AGONIST BINDING-SITES
    SEVERSON, JA
    RANDALL, PK
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1985, 233 (02) : 361 - 368
  • [34] DOPAMINE D-2 AND D-3 RECEPTORS IN THE RAT STRIATUM AND NUCLEUS-ACCUMBENS - USE OF 7-OH-DPAT AND [I-125] IODOSULPRIDE
    BOOZE, RM
    WALLACE, DR
    SYNAPSE, 1995, 19 (01) : 1 - 13
  • [35] C-11 AND I-125 IODOBENZAMIDE - A NEW LIGAND FOR PET AND SPECT IMAGING OF D2 DOPAMINE-RECEPTORS
    WONG, DF
    WILSON, AA
    DANNALS, RF
    RAVERT, HT
    GUNGON, R
    VILLEMAGNE, V
    LINKS, J
    WAGNER, HN
    JOURNAL OF NUCLEAR MEDICINE, 1987, 28 (06) : 1076 - 1076
  • [36] SELECTIVE LABELING OF THE DOPAMINE TRANSPORTER BY THE HIGH-AFFINITY LIGAND 3-BETA-(4-[I-125]IODOPHENYL)TROPANE-2-BETA-CARBOXYLIC ACID ISOPROPYL ESTER
    BOJA, JW
    CADET, JL
    KOPAJTIC, TA
    LEVER, J
    SELTZMAN, HH
    WYRICK, CD
    LEWIN, AH
    ABRAHAM, P
    CARROLL, FI
    MOLECULAR PHARMACOLOGY, 1995, 47 (04) : 779 - 786
  • [37] DOPAMINE-D2 RECEPTORS IN THE RAT, MONKEY AND THE POSTMORTEM HUMAN HIPPOCAMPUS - AN AUTORADIOGRAPHIC STUDY USING THE NOVEL D2-SELECTIVE LIGAND I-125 NCQ-298
    KOHLER, C
    ERICSON, H
    HOGBERG, T
    HALLDIN, C
    CHANPALAY, V
    NEUROSCIENCE LETTERS, 1991, 125 (01) : 12 - 14
  • [38] CHARACTERIZATION OF BETA-ADRENERGIC-RECEPTOR SUBTYPES IN ANDROGEN-INDUCED MOUSE KIDNEY HYPERTROPHY USING A NEW HIGH-AFFINITY LIGAND, [I-125]IODOCYANOPINDOLOL
    PETROVIC, SL
    ENGEL, G
    HAUGLAND, RP
    DOWBEN, RM
    BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 756 (03) : 286 - 296
  • [39] COMPLETE CONVERSION OF BRAIN D2 DOPAMINE-RECEPTORS FROM THE HIGH-AFFINITY TO THE LOW-AFFINITY STATE FOR DOPAMINE AGONISTS, USING SODIUM-IONS AND GUANINE-NUCLEOTIDE
    GRIGORIADIS, D
    SEEMAN, P
    JOURNAL OF NEUROCHEMISTRY, 1985, 44 (06) : 1925 - 1935
  • [40] [I-125](S)-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-5-IODO-2-METHOXYBENZAMIDE HYDROCHLORIDE, A NEW SELECTIVE RADIOLIGAND FOR DOPAMINE D-2 RECEPTORS
    DEPAULIS, T
    JANOWSKY, A
    KESSLER, RM
    CLANTON, JA
    SMITH, HE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1988, 196 : 72 - MEDI
12345